Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave

Emerg Microbes Infect. 2022 Dec;11(1):2045-2054. doi: 10.1080/22221751.2022.2109517.

Abstract

Shanghai has been experiencing the Omicron wave since March 2022. Though several studies have evaluated the risk factors of severe infections, the analyses of BA.2 infection risk and protective factors among geriatric people were much limited. This multicentre cohort study described clinical characteristics, and assessed risk and protective factors for geriatric Omicron severe infections. A total of 1377 patients older than 60 were enrolled, with 75.96% having comorbidities. The median viral shedding time and hospitalization time were nine and eight days, respectively. Severe and critical were associated with longer virus clearance time (aOR [95%CI]:0.706 (0.533-0.935), P = .015), while fully vaccinated/booster and paxlovid use shortened viral shedding time (1.229 [1.076-1.402], P = .002; 1.140 [0.019-1.274], P = .022, respectively). Older age (>80), cerebrovascular disease, and chronic kidney disease were risk factors of severe/critical. Fully vaccination was a significant protective factor against severe infections (0.237 [0.071-0.793], P = .019). We found patients with more than two comorbidities were more likely to get serious outcomes. These findings demonstrated that in the elderly older than 60 years old, older age (aged over 80), cerebrovascular disease, and chronic kidney disease were risk factors for severe infection. Patients with more than two comorbidities were more likely to get serious outcomes. Fully vaccinated/booster patients were less likely to be severe and vaccinations could shorten viral shedding time. The limitation of lacking an overall spectrum of COVID-19 infections among elders could be compensated in other larger-scale studies in the future.

Keywords: COVID-19; Omicron; elderly; risk factor; vaccination.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • COVID-19* / epidemiology
  • China / epidemiology
  • Cohort Studies
  • Humans
  • Middle Aged
  • Protective Factors
  • Renal Insufficiency, Chronic*

Grants and funding

This work was supported by the National Natural Science Foundation of China [grant number 82041010; 92169212; 82161138018], Shanghai Science and Technology Committee (20dz2260100, 21NL2600100, 20Z11901100, 20dz2210403).